期刊文献+

川崎病患儿治疗前后血清肿瘤坏死因子-α的变化及其意义 被引量:3

Changes of plasma levels of tumor necrosis factor-α (TNF-α) and its value in children with Kawasaki disease before and after treatment
原文传递
导出
摘要 目的:探讨川崎病(KD)患儿静脉注射用丙种球蛋白(IVIG)治疗前后血清肿瘤坏死因子-α(TNF-α)水平变化及其意义。方法:治疗组选择本院确诊KD患儿34例,分为冠状动脉损伤组14例和无冠状动脉损伤组20例;正常对照组选择年龄相仿的门诊体检健康儿童l5例。采用酶联免疫吸附法检测KD患儿经IVIG治疗前后及对照组血清TNF-α水平。结果:KD患儿治疗前急性期血清TNF-α水平明显高于正常对照组(P<0.01);与无冠状动脉损伤组比较,冠状动脉损伤组血清TNF-α水平升高更明显(P<0.05)。经IVIG治疗后KD患儿恢复期血清TNF-α水平明显降低(P<0.01)。结论:血清TNF-α水平在KD患儿急性期、尤其有冠状动脉损伤时明显升高;血清TNF-α可能参与KD冠状动脉损伤的病理过程。 Objective: To explore the change and clinical significance of plasma levels of TNF-α in children with Kawasaki disease (KD) (n = 34) before and after treatment with intravenous immunoglobulin (IVIG) . Methods: Children with KD were enrolled from June 2005 to July 2007, one group ( n = 14) with coronary artery lesions (CALs) and another group ( n = 20) without CALs. The control were enrolled from heathy children in clinic service. Enzyme -linked immunosorbent assay (ELISA) was used to detect the plasma levels of TNF - α in children with KD ( n = 34) before and after treatment with IVIG and in normal control group ( n = 15 ) respectively. Results: The plasma level of TNF - α in KD group before treatment with IVIG was significanly higher than that in control group (P 〈0. 01 ). Moreover, the plasma level TNF -α in KD with CALa before treatment with IVIG was significantly increased, compared with KD without CALs ( P 〈 0. 05 ). The plasma level of TNF - α in KD after treatmented with IVIG decreased obviously ( P 〈 0. 01 ) . Condusion: The plasma level of TNF - α in acute stage of KD significantly elevate, especially in KD with CALs. TNF -α may be involved in the formation of CALLs and pathogenesis of KD.
出处 《中国妇幼保健》 CAS 北大核心 2008年第36期5217-5218,共2页 Maternal and Child Health Care of China
关键词 粘膜皮肤淋巴结综合征 肿瘤坏死因子-Α 丙种球蛋白 Mueocutaneous lymph node syndrome Tumor necrosis factor-α Immunoglobulin
  • 相关文献

参考文献8

  • 1Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diagnosis, management, and long- term implications. Cardiol Rev, 2007, 15 (4): 163
  • 2刘颖.川崎病患儿PS、ES、VEGF血清含量变化的研究[J].中国妇幼保健,2006,21(18):2538-2539. 被引量:9
  • 3Hui - Yuen JS, Duong TT, Yeung RS. TNF - alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol, 2006, 176 (10) : 6294
  • 4Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, Treatment, and Long- Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics, 2004, 114 (6): 1708
  • 5Freeman AF, Shulman ST. Kawasaki Disease: Summary of the American Heart Association Guidelines. Am Fam Physician, 2006, 74 (7): 1141
  • 6Baer AZ, Rubin LG Shapiro CA et al. Prevalence of coronary artery lesions on the initial echoeardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med, 2006, 160 (7) : 686
  • 7Okada Y, Ikeda K, Yamanaka O et al. TNFalpha suppression of corneal epithelium migration. Mol Vis, 2007, 14 (13) : 1428
  • 8Stenbog EV, Windelborg B, Horlyck Aet al. The effect of TNFalpha blockade in complicated, refractory Kawasaki disease. Scand J Rheumatol, 2006, 35 (4): 318

二级参考文献6

  • 1Daiani AS,Taubert KA,Gerber MA et al.Diagnosis and therapy of Kawasaki disease in children.Circulatian,1993,87:1776
  • 2Fijnheer R,Frijns CJ,Korteweg J et al.The origin of P-selectin as a circulating plasma protein.Thromb Haemost,1997,77:1081
  • 3Dong Z M,Chapman S M,Brown A A et al.The combined role of P-and E-selectins in atherosclerosis.Clin Inverst,1998,102:145
  • 4Bevilacqua M P,stengelin S,Gimbrone M A et al.Endothelial leukocyte adhesion molecule 1:An inducible receptor for neutrophils related to complement regulatory proteins and lectins.Science,1989,243:1160
  • 5Hamamichi Y,Ichida F,Yu X et al.Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease:its possible role in progression of coronary artery lesions.Pediatr Res,2001,49 (1):74
  • 6Ohno T,Yuge T,Kariyazono H et al.Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.Eur J Pediatr,2002,161 (2):105

共引文献8

同被引文献23

  • 1周洪升,秦大勇.乌司它丁治疗胰腺炎的回顾性研讨[J].河南外科学杂志,2004,10(2):20-21. 被引量:1
  • 2张玲英,洪华,彭茜.急性期川崎病患儿血清sIL-2R CRP IL-6 IL-8 TNF-α的变化[J].西部医学,2005,17(2):171-172. 被引量:1
  • 3Miura M,Sugiura T, Aimi Y, et al.Effects ofulinastatin on PMNL and vascular endothelial injury in patients undergoing open heart surgerywith CPB[J].Masu I,1998;47(1):29-32.
  • 4Zaitsu M,Hamasaki Y, Tashiro K,et al.Ulinastatin,an elastase inhibitor, inhibits the increased mRNA expression of prostagland H2 synthase-type 2 in Kawasaki disease[J].J Infect Dis,2000; 181 (3): 1101-1109.
  • 5牛峰海,蔡文仙,单继平,王瑜,舒志荣.静脉滴注丙种球蛋白对川崎病患儿血清TNF-α的影响[J].天津医药,2007,35(10):786-787. 被引量:1
  • 6Satou GM, Giamelli J, Gewitz MH. Kawasaki disease:diagnosis, raanagement, and long-term implications. Cardiol Rev, 2007,15 (4) :163-169.
  • 7Chu MP, Wang D, Zhang YY, et al. Pachyman treatment improvesCIM + CD25 + Treg eounts and serum interleukin 4 and interfer- on levels in a mouse model of Kawasaki disease.. Mol Med Re- port,2012,5(5) : 1237-1240,.
  • 8Rowley AH, Shulman ST. Kawasaki disease. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson textbook of pediatrics. Philadeiphia: Saunders, 2000 : 725 -727.
  • 9Rowley AH, Shulman ST. New developments in the search for the etiologic agent of Kawasaki disease. New developments in the search for the etiologic agent of Kawasaki disease. Curt Opin Ped-iatr,2007,19( 1 ) :71-74.
  • 10Weng KP, Ho TY, Chiao YH, et al. Cytokine genetic polymor- phisms and susceptibility to Kawasaki disease in Taiwan Residents chil- dren. Circ J,2010,74 (12) :2726-2733.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部